Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Expands By 107.2%

VanEck Biotech ETF (NASDAQ:BBH) was the target of a significant growth in short interest in the month of February. As of February 13th, there was short interest totaling 14,260 shares, a growth of 107.2% from the January 29th total of 6,883 shares. Approximately 0.7% of the shares of the company are short sold. Based on an average trading volume of 7,038 shares, the days-to-cover ratio is presently 2.0 days. Based on an average trading volume of 7,038 shares, the days-to-cover ratio is presently 2.0 days. Approximately 0.7% of the shares of the company are short sold.

VanEck Biotech ETF Stock Up 1.4%

Shares of NASDAQ BBH traded up $2.64 during trading on Friday, reaching $197.17. 1,664 shares of the stock traded hands, compared to its average volume of 7,554. VanEck Biotech ETF has a 52-week low of $135.34 and a 52-week high of $202.91. The company has a 50-day moving average of $194.67 and a 200-day moving average of $183.10.

VanEck Biotech ETF Dividend Announcement

The firm also recently announced an annual dividend, which was paid on Friday, December 26th. Stockholders of record on Monday, December 22nd were paid a $0.9565 dividend. The ex-dividend date was Monday, December 22nd. This represents a dividend yield of 50.0%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. raised its holdings in VanEck Biotech ETF by 40,463.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 494,061 shares of the company’s stock valued at $93,506,000 after acquiring an additional 492,843 shares during the period. Raymond James Financial Inc. lifted its holdings in VanEck Biotech ETF by 245.9% during the 2nd quarter. Raymond James Financial Inc. now owns 67,940 shares of the company’s stock worth $10,414,000 after purchasing an additional 48,297 shares in the last quarter. LPL Financial LLC boosted its stake in VanEck Biotech ETF by 63.5% in the 4th quarter. LPL Financial LLC now owns 31,813 shares of the company’s stock worth $6,021,000 after purchasing an additional 12,351 shares during the period. Paragon Private Wealth Management LLC boosted its position in shares of VanEck Biotech ETF by 223.5% in the third quarter. Paragon Private Wealth Management LLC now owns 13,394 shares of the company’s stock valued at $2,219,000 after acquiring an additional 9,254 shares during the period. Finally, Bank of America Corp DE lifted its stake in VanEck Biotech ETF by 17.7% in the 2nd quarter. Bank of America Corp DE now owns 52,466 shares of the company’s stock worth $8,042,000 after purchasing an additional 7,898 shares in the last quarter. 32.05% of the stock is owned by institutional investors.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.